Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
NCT02098226 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2015-02-06
Summary
The study objective is to confirm that the MBT-CA System identifies medically significant bacteria and yeasts from an isolated colony from any sample type processed by the clinical laboratory. For this purpose MBT-CA test results will be compared to bi-directional sequencing results.
Conditions
Sponsors & Collaborators
-
Bruker Daltonics
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-09-30
- Completion
- 2015-03-31
Countries
- Germany
Study Locations
More Related Trials
-
Detection of Bloodstream Pathogens in Hematological Malignancies
NCT03896880 ·Status: COMPLETED
-
Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA
NCT01640886 ·Status: TERMINATED
-
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
NCT01898208 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
NCT05716425 ·Status: COMPLETED ·Phase: PHASE3
-
Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
NCT02281643 ·Status: COMPLETED ·Phase: PHASE2
-
Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections
NCT03808636 ·Status: UNKNOWN
-
MRSA Decolonization in Complicated Carriage
NCT05268120 ·Status: RECRUITING ·Phase: NA
-
Bacterial Microbiota In The Tonsils Of Children
NCT01270243 ·Status: COMPLETED
-
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
NCT00254527 ·Status: COMPLETED
-
A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection
NCT01223222 ·Status: COMPLETED ·Phase: PHASE2
-
Construct Validation of the BIOTICA Questionnaire
NCT04286230 ·Status: COMPLETED
-
Clinical Research for the Diagnosis of Tick-borne Diseases in Patients With Unexplained Acute Fever
NCT02618655 ·Status: UNKNOWN
-
Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage
NCT03009903 ·Status: UNKNOWN
-
Clinical Evaluation of the Residual Antimicrobial Activity
NCT04495920 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex
NCT00298922 ·Status: UNKNOWN ·Phase: PHASE2
-
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
NCT00523926 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)
NCT00771316 ·Status: TERMINATED ·Phase: PHASE3
-
Surveillance of Azole Resistance in Aspergillus Isolates in Taiwan
NCT03024281 ·Status: UNKNOWN
-
AMR-DetecTool for the Diagnostic of MDR Bacterial Infections
NCT05378217 ·Status: COMPLETED
-
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
NCT07228702 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
NCT00449644 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients
NCT06681025 ·Status: COMPLETED
-
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
NCT01222832 ·Status: COMPLETED ·Phase: PHASE2
-
BacLite Rapid MRSA Clinical Performance
NCT00541632 ·Status: TERMINATED
-
Adapting LFI for Melioidosis
NCT03528265 ·Status: COMPLETED